# Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study

> **NCT00477373** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 70 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** depakine chrono

## Key facts

- **NCT ID:** NCT00477373
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2008-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477373, "Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00477373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*